The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDukemount Capi. Regulatory News (DKE)

Share Price Information for Dukemount Capi. (DKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.036
Bid: 0.032
Ask: 0.04
Change: -0.0015 (-4.00%)
Spread: 0.008 (25.00%)
Open: 0.0375
High: 0.0375
Low: 0.036
Prev. Close: 0.0375
DKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

14 Dec 2023 09:56

RNS Number : 8372W
Dukemount Capital PLC
14 December 2023
 

14 December 2023

Dukemount Capital Plc

("Dukemount" or the "Company")

 Notice to shareholders for annual general meeting, further advance under existing funding agreement, settlement to achieve a reduction in existing debt and completion of Chesterfield Conversion of debt

The board of directors, Dukemount Capital Plc, a SPAC (as confirmed in the announcement of 12 September 2023), is pleased to confirm the following:

· A circular will be posted on Monday 18 December to hold the annual general meeting of the Company on 12 January 2024. The resolutions (the "Resolutions") at the annual general meeting will be to, inter alia, restructure the share capital of the Company given the current trading price being below the nominal value.

· Through extensive discussions with the existing noteholders (the "Investors") pursuant to the existing funding agreement (as detailed in the announcement of 11 October 2022) (the "Existing Funding"), the directors have executed a net advance of £40,000 to fund immediate capital requirements of the Company.

· The Investors have agreed an irrevocable conditional amendment to the Existing Funding as follows:

The existing debt (inclusive of the further £40,000 advance) will be reduced to £900,000 (being a decrease of over 20% of the accrued balances).

No interest or fees to accrue during the term (i.e. the outstanding balance is frozen).

All rights to receive warrants pursuant to the Existing Funding are released and waived.

24 month repayment term from the date of the amendment being effective

Upon completion of a reverse takeover, the Company may elect for either (a) the Existing Funding to be converted into equity at the relevant placing price for the RTO or (b) the Existing Funding will be repaid (i) 50% of the outstanding balance on completion, (ii) 25% - 13 months from completion and (iii) 25% - 24 months from completion.

The amendments are conditional on the passing of the Resolutions and the Chesterfield Conversion below.

 

· As previously announced, Chesterfield Capital Limited has undertaken to convert the existing £500,000 debt at 0.0065 per ordinary share in the Company (being 76,923,076 ordinary shares when calculated prior to the reorganisation as detailed in the Resolutions) (the "Chesterfield Conversion"). Chesterfield Capital Limited has issued a subscription which is only conditional on the passing of the Resolutions.

CEO Elect Paul Gazzard commented:

"The board of directors are working closely with its broker, Peterhouse Capital, to consider all capital raising opportunities and to review prospects with regards to an RTO. At present the Company has no proceedable RTO opportunities, but we continue to review those presented to the board and will continue to ensure the market is kept up-to-date on progress. The additional funding from the Investors ensures the Company is on track to finalise its annual report for the 30 September 2023 year end and intends to publish those within the required timetable. Further, the restructure of the Existing Funding and the Chesterfield Conversion simplifies considerably the historic liabilities of the Company, something which the board believes will have a positive impact on progressing a potential RTO. The circular for the annual general meeting will be posted next week."

For further information, please visit www.dukemountcapitalplc.com or contact:

 

Dukemount Capital Plc : Email info@dukemountplc.com

CEO: Paul Gazzard

Non-Executive Director: Geoffery Dart

 

Broker Enquiries:

Peterhouse Capital Limited Tel: +44 (0) 207 469 0930

Lucy Williams/Duncan Vasey

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOATIBLTMTABMIJ
Date   Source Headline
4th Aug 202011:25 amRNSHolding(s) in Company
1st Jul 20207:48 amRNSHolding(s) in Company
30th Jun 20207:00 amRNSAppointment of Chief Executive Officer
26th Jun 20209:45 amRNSHolding(s) in Company
23rd Jun 202010:46 amRNSHolding(s) in Company
15th Jun 20201:31 pmRNSHolding(s) in Company
10th Jun 20202:28 pmRNSExercise of Warrants - Issue of Equity
18th May 20203:26 pmRNSWavertree COVID-19 Update.
7th May 202010:02 amRNSHolding(s) in Company
5th May 20201:24 pmRNSAdmission To Trading For Placing Shares
1st May 202011:21 amRNSAdmission To Trading For Bonus Shares
30th Apr 20204:59 pmRNSHolding(s) in Company
22nd Apr 20207:00 amRNSIssue of Equity
9th Apr 20207:00 amRNSWest Derby COVID-19 Update
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 202011:01 amRNSWavertree COVID-19 Update
26th Mar 20207:00 amRNSWavetree Project at Final Fit Out
23rd Mar 20204:17 pmRNSResult of AGM
19th Mar 20208:30 amRNSStatement re AGM
26th Feb 20202:00 pmRNSNotice of AGM
29th Jan 20204:41 pmRNSSecond Price Monitoring Extn
29th Jan 20204:35 pmRNSPrice Monitoring Extension
29th Jan 20202:45 pmRNSHalf-year Report
30th Aug 20193:08 pmRNSFinal Results
31st Jul 20194:41 pmRNSSecond Price Monitoring Extn
31st Jul 20194:35 pmRNSPrice Monitoring Extension
25th Jul 201910:10 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSWest Derby Development Update
17th Jun 20197:00 amRNSNew Website Released
10th Jun 20192:44 pmRNSHolding(s) in Company
7th Jun 201911:07 amRNSHolding(s) in Company
5th Jun 20191:44 pmRNSHolding(s) in Company
3rd Jun 20194:44 pmRNSHolding(s) in Company
30th May 20193:40 pmRNSHolding(s) in Company
29th May 201910:20 amRNSHolding(s) in Company
20th May 20193:26 pmRNSHolding(s) in Company
20th May 201911:14 amRNSHolding(s) in Company
14th May 201910:31 amRNSHolding(s) in Company
26th Apr 20191:03 pmRNSHolding(s) in Company
2nd Apr 20197:00 amRNSCompletion of West Derby Building Contract
25th Mar 20197:00 amRNSCompletion of Wavertree Building Contract
12th Feb 201910:19 amRNSHolding(s) in Company
11th Feb 20194:00 pmRNSResultant Holding Following Issue of Shares
4th Feb 20197:00 amRNSBoard Change
4th Feb 20197:00 amRNSResult of AGM
31st Jan 20197:20 amRNSIssue of Shares
31st Jan 20197:10 amRNSInterim Results
31st Jan 20197:00 amRNSWavertree Development Agreement
8th Jan 20197:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.